Awarded contractOpenSuppliesGermany
Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Dasatinib (Zulassung mindestens für CML), ATC L01XE06 für die Zeit 01.08.2022 - 31.07.2024
1 lot awarded
Buyer: DAK-Gesundheit / Hamburg, Germany
Published Jan 19, 2024
Pharmaceutical products
Awarded value
Not specified
Estimated value
Not specified
Award date
—
Winners
0
Lots awarded
1
Winners
No winners specified.
Lots awarded
| Lot | Title | Winner | Award value | Main CPV |
|---|---|---|---|---|
| LOT-0001 | Not specified | — | Pharmaceutical products (33600000) |